Delivery Order SPE2DB22D3009-SPE2DB25FAJ85
Award Date
11/18/24
Potential Completion Date
11/19/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,055.56 firm fixed-price award is for the supply of a pharmaceutical product, Hydrocortisone-Pramoxine 2.5-1% Cream, 28.4 grams. The contract has an ultimate completion date of April 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,815.25 delivery order contract is for the supply of Hydrocort-Pramoxine 2.5-1% Cream, a pharmaceutical product. The contract has an ultimate completion date of August 18, 2022 and is a firm fixed-price delivery order. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $61,215.57, is for the delivery of Hydrocort-Pramoxine 2.5-1% cream, which is a pharmaceutical product used for medical treatment. The contract has a completion date of May 10, 2024 and is a firm fixed-price delivery order. This contract is not associated with any set-aside designation, indicating that it was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.98 fixed-price delivery order is for the supply of HYDROCORT-PRAMOXINE 2.5-1% CRM 4GM, a pharmaceutical product. The contract has a period of performance through May 15, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,950.78, is for the delivery of 4563117240 HYDROCORT-PRAMOXINE 2.5-1% CRM 28.4GM, a medical supply. The contract has a firm fixed price pricing type and an ultimate completion date of December 18, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,622.91 to AmerisourceBergen Drug Corp for the supply of 4567330281 - Hydrocortisone 1% Cream 28.4GM. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,027.92, is for the delivery of 4567421431 HYDROCORTISONE 2.5% CREAM 30GM. It is a firm fixed-price delivery order contract with a completion date of March 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award issued by the Defense Logistics Agency (DLA) is for the delivery of Hydrocortisone-Pramoxine 2.5%-1% cream, a pharmaceutical product, to support federal healthcare programs. The $3,003.61 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 3, 2023. The contract has a completion date of July 5, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HYDROCORT-PRAMOXINE 2.5-1% CRM 30GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,475.91 and a period of performance through May 14, 2025. There is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This federal contract award, valued at $1,642.18, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Hydrocort-Pramoxine 2.5-1% Cream in 28.4 gram quantities, with a completion date of January 12, 2024. The contract is not designated as a set-aside and was awarded as a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays...